Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
News|Videos|March 2, 2026

FDA Issues De Novo Clearance of Ultrasound AI Software for Delivery Date Prediction

Author(s)Jeff Hall

Offering reportedly seamless integration into workflows for prenatal evaluations and real-time decision-making, the cloud-based Delivery Date AI software was trained on millions of ultrasound images from diverse pregnancies.

The Food and Drug Administration (FDA) has granted De Novo clearance for Delivery Date AI, a cloud-based software that utilizes AI to help predict delivery dates based on standard ultrasound images.

Powered by deep learning neural networks for ultrasound image assessment, the Delivery Date AI software was trained on millions of ultrasound images across diverse pregnancies and health-care settings, according to Ultrasound AI, the developer of Delivery Date AI.

A 2025 study of the Delivery Date AI software, published in the Journal of Maternal-Fetal and Neonatal Medicine, revealed an R2 value of 92 percent for preterm birth prediction.

"Fetal development and delivery timing impact nearly every decision in obstetrics," said Nathan Fox, M.D., board-certified OBGYN, maternal fetal medicine specialist, and partner physician with Ultrasound AI. "Delivery Date AI gives clinicians unprecedented insight into a pregnancy's progression, allowing us to make more informed decisions for how and when we intervene. This technology has transformative implications for maternal and fetal health care."


Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.